Clifford Brechner | Colliers International | Philadelphia

Clifford Brechner

Vice President

Call Clifford
View More View Less


Professional Summary

Clifford Brechner joined Colliers in 2019 to focus his talents in the fast-growing Philadelphia Life Sciences division. 

Clifford comes to Colliers with more than 35 years of experience leading companies with revenues in excess of $10 million. For the past 20 years Brechner has led ventures within the analytical laboratory and quality assurance industry, making him exceptionally suited to help laboratory clients navigate their complicated real estate needs in an ever-changing market. 

Clifford is a native of New York and currently resides in Bryn Mawr with his wife and two children. 



As Founder and CEO of Insight Laboratories, a consumer products safety testing lab, Clifford built and managed facilities in Singapore, Hong Kong, Shanghai, Canada and California, New York, Connecticut, and Pennsylvania.  With rapid growth and ISO17025 and Consumer Product Safety Commission approval, Insight was acquired by a strategic partner. 

As Co-Founder and CEO of Actus Analytical, Clifford also managed the development, marketing and sales of instruments for consumer safety compliance screening. Under Clifford’s leadership, Actus Analytical was awarded a research grant from U.S. Department of Homeland Security and the CPSC, and partnered with Agilent Technologies to develop a portable analytical instrument for the screening of material ID.

Memberships & Involvements

Licensed Real Estate Salesperson in Pennsylvania


Service Lines
Landlord Representation, Tenant Representation, Occupier Services
Property Type
Life Sciences Group

My Team

My Team

Featured Research
Jun 24, 2020
Mid-Year Update: COVID-19 Impact on the Life Sciences Real Estate Sector
Lab productivity is recovering. COVID-related investigations are on a fast track. Expansion requirements are back on pace, even exceeding pre-COVID levels.
Read More
Mar 24, 2020
SARS-CoV-2 Impact on the Life Sciences Real Estate Sector
Learn the five trends facing the lab real estate sector as we react to a global pandemic in a new Colliers Life Sciences whitepaper report.
Read More
Feb 25, 2020
In-House or Outsource? Considerations for Biotechs at the Drug Manufacturing Crossroads
In house or outsource to a CDMO? Five considerations for pre-clinical and clinical drug development companies facing critical manufacturing decisions, authored by Joseph Fetterman of the Colliers Life Sciences Practice Group.
Read More
View More
Featured News
Jul 24, 2019
Clifford Brechner Joins the Colliers International Life Sciences Team
Lab Industry Entrepreneur Turns Real Estate Advisor
Read More
View More

How can I help you?

An unexpected error has occurred. Please try again.
Your request has been submitted.
Someone will contact you shortly.